Viceroy Ventures

Profile

Viceroy Ventures is an early to mid-stage investment firm based in New York City. The firm strategically selects investments in disruptive companies across various sectors. Their approach is centered on identifying promising early and mid-stage ventures poised for significant growth potential. Although the team size and specific team members are not disclosed, they express a passion for solving future transportation problems, indirectly indicating a focus on innovative sectors. Established in 2015, Viceroy Ventures is positioned as a versatile and committed player in the investment landscape.

The firm diversifies its portfolio by investing across multiple sectors, including early to mid-stage companies. While specific check sizes are not listed, Viceroy Ventures targets early-stage to mid-stage investments, suggesting an investment range likely between $1-5 m and $5-10 m. Their geographical focus is mainly in North America, supported by their New York headquarters.

Current notable investments include Novocure - oncology treatment, Dataminr - real-time information discovery, Lumicell - cancer treatment, FREDA SALVADOR - fashion footwear, and Jianke - pharmaceutical retail. These investments reflect the firm's focus on sectors like technology, healthcare, and fashion, among others.